 Home > Active Ingredient News > Blood System > Express progression-free survival is better than standard therapy, and BCMA-targeted CAR-T therapy reaches the primary endpoint of Phase 3 clinical trials

Express progression-free survival is better than standard therapy, and BCMA-targeted CAR-T therapy reaches the primary endpoint of Phase 3 clinical trials

 Last Update: 2022-08-20
 Source: Internet
 Author: User

▎Edited by WuXi AppTec Content Team

Bristol-Myers Squibb (BMS) and 2seventy bio today jointly announced that their chimeric antigen receptor (CAR) T-cell therapy Abecma (idecabtagene viccleucel) is in the treatment of KarMMa-3 in patients with relapsed or refractory multiple myeloma (RRMM).

Multiple myeloma is a still incurable cancer of blood cells that primarily affects cells in the bone marrow called plasma cells

[1] Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma (idecabtagene vicleucel) Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma.

Disclaimer: The WuXi AppTec content team focuses on introducing global biomedical health research progress

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

China Largest Manufacturer Supply High Purity Etamsylate CAS 2624-44-4

CAS No.: 2624-44-4

Pharmacy Grade

$3-3.5/KG FOB

Factory Supply Clarithromycin with High Quality 201530-41- 8

CAS No.: 201530-41-8

Pharmacy Grade

$3-3.5/KG FOB

Ferrous Fumarate

CAS No.: 141-01-5

Feed Grade

$5.8/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.